Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Antibodies, Viral”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT01333813
What this trial is testing

Hepatitis B Antibody Persistence and Immune Response to Hepatitis B Vaccine Challenge in Previously Vaccinated Children

Who this might be right for
Hepatitis B
GlaxoSmithKline 300
Not applicableStudy completedNCT00004851
What this trial is testing

Generation of Anti-HCV Antibodies From Bone Marrow: Defining the Repertoire of Immune Response to HCV Quasispecies

Who this might be right for
Hepatitis C
National Institutes of Health Clinical Center (CC) 1
Not applicableLooking for participantsNCT06584045
What this trial is testing

Efficacy and Safety of Calculus Bovis Sativus (CBS) for Adult Encephalitis (CBSinEncephalitis)

Who this might be right for
EncephalitisEncephalitis, ViralAutoimmune Encephalitis Caused by N-Methyl D-Aspartate Receptor Antibody+1 more
Tongji Hospital 250
Early research (Phase 1)Study completedNCT01756950
What this trial is testing

Assessment of CR8020, a Monoclonal Antibody Against Influenza A Viruses

Who this might be right for
Influenza
Crucell Holland BV 64
Not applicableStudy completedNCT00163618
What this trial is testing

Study to Investigate the Seropersistence of TBE Virus Antibodies Approx. 3 Years After a Booster Vaccination With FSME-IMMUN 0.25 mL JUNIOR in Children

Who this might be right for
Encephalitis, Tick-borne
Pfizer
Not applicableStudy completedNCT04690413
What this trial is testing

NOWDx Test for the Detection of Antibodies to COVID-19

Who this might be right for
COVID-19SARS-CoV-2Coronavirus
NOWDiagnostics, Inc. 129
Testing effectiveness (Phase 2)Ended earlyNCT04432298
What this trial is testing

Study of the Efficacy and Safety of Intravenous Pamrevlumab, in Hospitalized Participants With Acute COVID-19 Disease

Who this might be right for
COVID-19
Kyntra Bio 22
Not applicableStudy completedNCT04904835
What this trial is testing

Access HBV Assays - European Union (EU) Clinical Trial Protocol -

Who this might be right for
HBV
Beckman Coulter, Inc. 21,210
Post-approval studies (Phase 4)Study completedNCT01037114
What this trial is testing

Long-term Persistence Study in Healthy Adults Previously Vaccinated With Twinrix Adult

Who this might be right for
Hepatitis AHepatitis B
GlaxoSmithKline 50
Post-approval studies (Phase 4)Study completedNCT01358825
What this trial is testing

Study to Evaluate Antibody Persistence in Children Previously Vaccinated With Infanrix Hexa™ or Infanrix-IPV/Hib™

Who this might be right for
TetanusPoliomyelitisHaemophilus Influenzae Type b+4 more
GlaxoSmithKline 58
Not applicableStudy completedNCT04416308
What this trial is testing

COVID 19 : Seroprevalence Study of Anti SRAS-CoV-2 Antibodies in GHT Employees in Haute Bretagne (AntiCoV-HB)

Who this might be right for
Coronavirus
Rennes University Hospital 9,453
Not applicableStudy completedNCT05104359
What this trial is testing

COVID-19 Quantitative Antibody Titers & Booster Vaccinations

Who this might be right for
COVID-19COVID-19 VaccinesImmunogenicity, Vaccine
Epividian 825
Not applicableStudy completedNCT05148806
What this trial is testing

Mass Evaluation of Lateral Flow Immunoassays for the Detection of SARS-CoV-2 (Covid-19) Antibodies

Who this might be right for
Solid Organ Transplant RecipientsAutoimmune DiseasesHaematological Malignancies
Imperial College London 28,411
Post-approval studies (Phase 4)UnknownNCT05982704
What this trial is testing

Study of Tixagevimab/Cilgavimab and Regdanvimab Efficacy for Treatment of COVID-19

Who this might be right for
Coronavirus Infections
City Clinical Hospital No.52 of Moscow Healthcare Department 82
Testing effectiveness (Phase 2)Study completedNCT04551898
What this trial is testing

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Neutralizing Antibody BGB-DXP593 in Participants With Mild-to-Moderate Coronavirus Disease 2019 (COVID-19)

Who this might be right for
Covid19
BeiGene 181
Early research (Phase 1)Study completedNCT00001105
What this trial is testing

The Safety and Effectiveness of Human Monoclonal Antibody, F105, in the Treatment of HIV

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 8
Early research (Phase 1)Study completedNCT02579083
What this trial is testing

Safety Study of Monoclonal Antibodies to Reduce the Vaginal Transmission of HSV and HIV

Who this might be right for
HIVHerpes Simplex Infections
KBio Inc 38
Not applicableUnknownNCT04944095
What this trial is testing

Change in Antibody Levels Following SARS-CoV-2 (Covid-19) Vaccinations

Who this might be right for
Covid-19Subjects Vaccinated Against Covid-19
Dr. Sidney J. Stohs 10,000
Not applicableUnknownNCT06582654
What this trial is testing

Normalizing Antibody Detection in First-void Urine

Who this might be right for
Human Papillomavirus Infection
Universiteit Antwerpen 150
Not applicableStudy completedNCT04895475
What this trial is testing

Antibody Detection of Vaccine-Induced Secretory Effects

Who this might be right for
Covid19Humoral Acquired ImmunodeficiencyCoronavirus+1 more
Children's Hospital Medical Center, Cincinnati 61
Next Page